CH Weaver

518 total citations
16 papers, 411 citations indexed

About

CH Weaver is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, CH Weaver has authored 16 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Hematology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in CH Weaver's work include Neutropenia and Cancer Infections (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Lung Cancer Research Studies (4 papers). CH Weaver is often cited by papers focused on Neutropenia and Cancer Infections (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Lung Cancer Research Studies (4 papers). CH Weaver collaborates with scholars based in United States. CH Weaver's co-authors include CD Buckner, B Zhen, West Wh, FA Greco, John D. Hainsworth, C. Dean Buckner, B Hazelton, Wei Li, Paul Kaywin and L. Schwartzberg and has published in prestigious journals such as Bone Marrow Transplantation and PubMed.

In The Last Decade

CH Weaver

16 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CH Weaver United States 14 250 248 86 54 48 16 411
B Zhen China 10 165 0.7× 233 0.9× 75 0.9× 63 1.2× 29 0.6× 13 337
R. Erttmann Germany 9 112 0.4× 190 0.8× 46 0.5× 32 0.6× 20 0.4× 16 344
Emma L. Clarke United Kingdom 8 177 0.7× 318 1.3× 30 0.3× 85 1.6× 22 0.5× 12 435
H. Gerhartz Germany 10 120 0.5× 90 0.4× 114 1.3× 76 1.4× 36 0.8× 42 357
J. Q. K. Ho Australia 7 203 0.8× 411 1.7× 38 0.4× 98 1.8× 10 0.2× 14 480
Laurence Detourmignies France 9 100 0.4× 237 1.0× 87 1.0× 70 1.3× 14 0.3× 16 402
Jacqueline Maaloufová Czechia 9 67 0.3× 231 0.9× 102 1.2× 74 1.4× 30 0.6× 16 345
F. M. Fink Austria 11 68 0.3× 190 0.8× 70 0.8× 60 1.1× 21 0.4× 21 439
Jacob Haaber Denmark 8 192 0.8× 87 0.4× 124 1.4× 64 1.2× 30 0.6× 13 336

Countries citing papers authored by CH Weaver

Since Specialization
Citations

This map shows the geographic impact of CH Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CH Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CH Weaver more than expected).

Fields of papers citing papers by CH Weaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CH Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CH Weaver. The network helps show where CH Weaver may publish in the future.

Co-authorship network of co-authors of CH Weaver

This figure shows the co-authorship network connecting the top 25 collaborators of CH Weaver. A scholar is included among the top collaborators of CH Weaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CH Weaver. CH Weaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Weaver, CH, et al.. (2002). Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy. Bone Marrow Transplantation. 29(2). 159–164. 4 indexed citations
2.
3.
Weaver, CH, Barbara Mcaneny, B Zhen, et al.. (1999). High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast. Bone Marrow Transplantation. 24(9). 981–987. 14 indexed citations
4.
Weaver, CH, et al.. (1998). Phase I–II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma. Bone Marrow Transplantation. 22(3). 245–251. 24 indexed citations
5.
Birch, Robert, CH Weaver, K. Carson, & CD Buckner. (1998). A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin. Bone Marrow Transplantation. 22(7). 685–688. 6 indexed citations
6.
Weaver, CH, TJ Moss, B Zhen, et al.. (1998). High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells. Bone Marrow Transplantation. 21(11). 1117–1124. 27 indexed citations
7.
Weaver, CH, et al.. (1998). High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin’s lymphoma. Bone Marrow Transplantation. 21(4). 383–389. 25 indexed citations
8.
Singer, Jack W., K Schiffman, Leona Holmberg, et al.. (1997). High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer. Bone Marrow Transplantation. 19(12). 1183–1189. 26 indexed citations
9.
Weaver, CH, Janice Redmond, Paul Kaywin, et al.. (1997). Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content. Bone Marrow Transplantation. 19(11). 1103–1110. 52 indexed citations
10.
Weaver, CH, John D. Hainsworth, FA Greco, et al.. (1997). Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers. Bone Marrow Transplantation. 19(7). 671–678. 57 indexed citations
11.
Weaver, CH, Lee S. Schwartzberg, B Zhen, et al.. (1997). High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin’s lymphoma: results of outpatient treatment in community cancer centers. Bone Marrow Transplantation. 20(9). 753–760. 25 indexed citations
12.
13.
Weaver, CH, Robert Birch, John D. Hainsworth, et al.. (1997). Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer.. PubMed. 3(2). 83–90. 17 indexed citations
14.
Weaver, CH, FA Greco, B Zhen, et al.. (1997). A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma. Bone Marrow Transplantation. 20(10). 847–853. 21 indexed citations
15.
Weaver, CH, Lee S. Schwartzberg, Wei Li, B Hazelton, & W. H. West. (1996). High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.. PubMed. 17(5). 715–21. 17 indexed citations
16.
Demirer, Taner, CD Buckner, Appelbaum Fr, et al.. (1995). Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.. PubMed. 15(6). 915–22. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Zhen Breakdown of academic impact, for papers by R. Erttmann Breakdown of academic impact, for papers by Emma L. Clarke Breakdown of academic impact, for papers by H. Gerhartz Breakdown of academic impact, for papers by J. Q. K. Ho Breakdown of academic impact, for papers by Laurence Detourmignies Breakdown of academic impact, for papers by Jacqueline Maaloufová Breakdown of academic impact, for papers by F. M. Fink Breakdown of academic impact, for papers by Jacob Haaber
Rankless by CCL
2026